| 000 | 01824 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514003647.0 | ||
| 264 | 0 | _c20010913 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a1524-4636 | ||
| 024 | 7 |
_a10.1161/hq0701.092143 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYoshida, M | |
| 245 | 0 | 0 |
_aHmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism. _h[electronic resource] |
| 260 |
_bArteriosclerosis, thrombosis, and vascular biology _cJul 2001 |
||
| 300 |
_a1165-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aADP Ribose Transferases _xpharmacology |
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 | _aBotulinum Toxins |
| 650 | 0 | 4 | _aCell Adhesion |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aIntegrins _xmetabolism |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPolymers _xmetabolism |
| 650 | 0 | 4 | _aProtein Transport |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aU937 Cells |
| 650 | 0 | 4 |
_arhoA GTP-Binding Protein _xantagonists & inhibitors |
| 700 | 1 | _aSawada, T | |
| 700 | 1 | _aIshii, H | |
| 700 | 1 | _aGerszten, R E | |
| 700 | 1 | _aRosenzweig, A | |
| 700 | 1 | _aGimbrone, M A | |
| 700 | 1 | _aYasukochi, Y | |
| 700 | 1 | _aNumano, F | |
| 773 | 0 |
_tArteriosclerosis, thrombosis, and vascular biology _gvol. 21 _gno. 7 _gp. 1165-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/hq0701.092143 _zAvailable from publisher's website |
| 999 |
_c11380191 _d11380191 |
||